184 related articles for article (PubMed ID: 15688779)
1. [Physical and chemical characterization of allantoin-beta-cyclodextrin inclusion complex].
Gafiţanu C; Popescu C; Singurel G; Macocinschi D
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):173-6. PubMed ID: 15688779
[TBL] [Abstract][Full Text] [Related]
2. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of alpha-hydrocycholic-beta-cyclodextrin inclusion compound].
Bian YH; Zhang DY; Xiong QP
Zhong Yao Cai; 2007 Nov; 30(11):1452-5. PubMed ID: 18323220
[TBL] [Abstract][Full Text] [Related]
6. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
10. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
11. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
12. Investigation of water-soluble inclusion complex of hypericin with β-cyclodextrin polymer.
Zhang W; Gong X; Cai Y; Zhang C; Yu X; Fan J; Diao G
Carbohydr Polym; 2013 Jun; 95(1):366-70. PubMed ID: 23618281
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
14. Preparation and study on the solid inclusion complex of cloxacillin sodium with beta-cyclodextrin.
Chao JB; Zhang BT
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Sep; 68(1):108-12. PubMed ID: 17321790
[TBL] [Abstract][Full Text] [Related]
15. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
Yuexian F; Junfen L; Chuan D
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
[TBL] [Abstract][Full Text] [Related]
16. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
Yang B; Lin J; Chen Y; Liu Y
Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and spectral investigation of Al(III) catechin/beta-cyclodextrin and Al(III) quercetin/beta-cyclodextrin inclusion compounds.
Dias K; Nikolaou S; De Giovani WF
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):154-61. PubMed ID: 18054838
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexes of phosphorylated daidzein derivatives with β-cyclodextrin: Preparation and inclusion behavior study.
Xiao Y; Yang L; Mao P; Yuan J; Deng Y; Qu L
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jan; 85(1):298-302. PubMed ID: 22041503
[TBL] [Abstract][Full Text] [Related]
20. Studies on coumestrol/beta-cyclodextrin association: Inclusion complex characterization.
Franco C; Schwingel L; Lula I; Sinisterra RD; Koester LS; Bassani VL
Int J Pharm; 2009 Mar; 369(1-2):5-11. PubMed ID: 19028558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
